Cold Laser Therapy Market Report Scope & Overview:

The Cold Laser Therapy Market was valued at USD 0.13 Billion in 2025 and is projected to reach USD 0.23 Billion by 2035, expanding at a CAGR of 5.62% during the forecast period 2026–2035.

Cold lasers are being used increasingly in the market due to the growing trend among healthcare providers to use non-invasive techniques for treating pain, rehabilitation, and inflammatory diseases. Low-level laser therapy (LLLT), which is also known as photobiomodulation therapy, has seen greater acceptance among practitioners as this therapy stimulates cell activity, improves microcirculation, decreases inflammation, and facilitates tissue regeneration without causing any thermal damage. Increasing prevalence of chronic pain problems, sports injuries, arthritis, diabetes ulcers, and musculoskeletal problems associated with aging has been fueling demand for cold lasers in hospitals and rehabilitation clinics. Moreover, commercialization of small handheld devices, advanced treatment procedures, and preference for painless treatments are helping the market grow further in the long run.

In addition, advances in technology are changing the dynamics of competition in the market as new innovations in the form of wearable photobiomodulation devices, multi-wavelength laser systems, AI-based treatment planning software, and portable home use devices have been taking place.

Market Size and Forecast      

• Market Size 2026E: USD 0.14 Billion

• Market Size 2035: USD 0.23 Billion

• CAGR: 5.62% from 2026 to 2035

• Fastest Growing Region: Asia Pacific

• Largest Region: North America

Cold Laser Therapy Market Trends

• Growing adoption of wearable photobiomodulation therapy devices across home healthcare.

• Increasing utilization of non-invasive laser therapy for chronic pain management.

• Rising integration of AI-enabled treatment planning in rehabilitation therapies.

• Expansion of portable handheld laser devices for outpatient clinical applications.

• Growing investments supporting regenerative medicine and tissue healing technologies.

The U.S. Cold Laser Therapy Market Size Outlook                  

The U.S. Cold Laser Therapy Market was valued at USD 0.05 billion in 2025 and is expected to reach approximately USD 0.08 billion by 2035, expanding at a CAGR of 4.78% during 2026–2035.

Domination of the cold laser therapy market in North America by the US will continue due to the presence of highly developed rehabilitation facilities, increased incidence of chronic conditions involving the musculoskeletal system, growing interest in the development of sports medicine, and the preference of non-drug solutions in the management of pain. The inclusion of photobiomodulation equipment in orthopedic clinics, rehabilitation centers, Technological innovations in laser systems, positive uptake by the professional sports sector, and the growth in awareness of minimally invasive techniques for therapy have contributed to the increased demand for such services in the country.

Additionally, the innovation in mobile laser platforms, wearables, artificial intelligence technology-based therapy optimization, and remote patient monitoring systems is making treatments more accessible and effective. Manufacturers are actively developing multi-wavelength lasers of high usability for both professional and at-home usage. In January 2025, the American Physical Therapy Association was furthering its emphasis on rehabilitation based on the use of evidence-informed practice, including the non-drug modalities, such as photobiomodulation, and health information networks and the safe exchange of the electronic health information.

Cold Laser Therapy Market Segment Analysis

• By Product Type, handheld cold laser devices dominated the market with 35.00% share in 2025, while wearable photobiomodulation devices are projected to witness the fastest growth with 8.90% CAGR during the forecast period.

• By Application, pain management dominated the market with 34.00% share in 2025, while wound healing is projected to witness the fastest growth with 6.55% CAGR during the forecast period.

• By End User, hospitals dominated the market with 31.00% share in 2025, while home healthcare is projected to witness the fastest growth with 8.71% CAGR during the forecast period.

By Product Type, handheld cold laser devices dominated, while wearable photobiomodulation devices grows fastest.

The market share held by handheld cold laser devices in 2025 was 35.00% owing to their convenience, affordability, usability, and wide acceptance among hospitals, physiotherapy centers, chiropractic centers, and sports injury clinics. This product line allows healthcare professionals to administer targeted photobiomodulation treatment of musculoskeletal conditions, chronic pain, tendon injury, arthritis, and soft tissue inflammation without requiring long-time setup process. In 2025, Erchonia Corporation increased visibility for its low-level laser therapy product range through educational activities emphasizing pain management and rehabilitation, thus facilitating wider professional use of handheld photobiomodulation systems.

Wearable photobiomodulation devices are expected to exhibit the highest CAGR of 8.90% between 2026 and 2035 due to growing patient preference for home-based rehabilitation, constant therapy delivery, advanced technologies of wireless devices, and increased demands for convenient chronic pain management products. Wearable photobiomodulation devices increase the access to the treatment by allowing patients to receive treatment not only in clinical setting, but maintaining adherence to the therapy. Introduction of rechargeable batteries, ergonomic design, mobile application compatibility, and individualized therapeutic regimen is driving commercialization.  THOR Photomedicine Ltd. continues growing education and research collaborations in order to promote use of wearable and portable photobiomodulation technologies for rehabilitation.

By Application, pain management dominated, while wound healing grows fastest.

In 2025, pain management captured 34.00% of the global cold laser therapy market driven by the high prevalence of chronic back pain, osteoarthritis, neck pain, neuropathic pain, and post-operative pain. There is a growing trend among medical professionals to use cold laser therapy as an alternative treatment without medications, which decreases inflammation, stimulates cellular regeneration, and improves functional rehabilitation without any invasive procedure. Multimodal non-opioid pain management remains highly emphasized by the American Academy of Pain Medicine in 2025, resulting in an increased interest of practitioners to complementary modalities including photobiomodulation.

In 2025, the growth rate for the wound healing application will be the highest of 6.55% as there is an increasing incidence of diabetic foot ulcers, surgical incisions, pressure ulcers, and non-healing wounds. Cold laser therapy increases tissue regeneration by boosting mitochondrial function, collagen production, promoting local blood circulation, and decreasing inflammation. The increasing body of clinical evidence about the effectiveness of photobiomodulation in wound repair, as well as the growing numbers of people with diabetes and elderly patients, is prompting clinicians to implement laser therapy in their advanced wound care protocols. In 2025, Wound Healing Society was actively promoting research on advanced wound care methods, including photobiomodulation treatments.

By End User, hospitals dominated, while home healthcare grows fastest.

The hospitals occupied 31.00% share of the Cold Laser Therapy Market in 2025 as a result of increased adoption of innovative rehabilitation technologies and multi-disciplinary pain management facilities, along with high volumes of patients seeking non-invasive treatments. High-end hospitals have been continuously investing in photobiomodulation equipment used in orthopedic rehabilitation, postoperative recovery, neurological rehabilitation, sports injuries, and chronic pain management. Skilled healthcare specialists, rehabilitation programs, and integration of laser therapy with physiotherapy and musculoskeletal care further enhance the market dominance of the segment. American Hospital Association focused on investment in innovative rehabilitation technologies and technology-driven patient recovery programs in 2025, contributing to the wide application of non-invasive therapies at hospitals.

Home healthcare will experience the highest CAGR of 8.71% over 2026-2035 as a result of increasing preference for home-based treatments, increased population of the elderly, and higher prevalence of chronic musculoskeletal diseases that require long-term therapy. Innovations in portable and easy-to-use laser devices featuring programmable settings, rechargeable batteries, and digital control capabilities will facilitate the trend. American Physical Therapy Association promoted digital rehabilitation and telemedicine care delivery models in 2025, furthering the use of home-based therapy solutions, including portable photobiomodulation equipment.

Regional Analysis                                             

North America Cold Laser Therapy Market Insights

The share of the cold laser therapy market revenue held by North America was estimated at 39.00% in 2025 due to its well-developed rehabilitation facilities, popularization of non-invasive pain treatment, and increasing use of photobiomodulation technology in the clinic. Such factors as higher spending on healthcare, greater spread of chronic musculoskeletal disorders, development of sports medicine programs, and investments in advanced physiotherapy equipment contribute to such a positive trend.

In addition, hospitals, rehabilitation centers, orthopedic and chiropractic clinics keep introducing cold laser therapy into their treatment schemes to increase recovery efficiency and reduce the need for pain management using drugs. Besides, the presence of key manufacturers, good regulation of medical devices, and innovations in products make North America one of the dominating markets for photobiomodulation technologies. Erchonia Corporation launched the expansion of its FDA-cleared portfolio of low-level laser therapy in 2025.

Europe Cold Laser Therapy Market Insights   

The European region will remain one of the lucrative markets for cold laser therapy, owing to established healthcare infrastructure, increasing use of non-invasive rehabilitation techniques, and rising awareness about photobiomodulation for pain relief and tissue healing. In nations like Germany, the UK, France, Italy, and Spain, there is an increasing use of laser therapy equipment in hospitals, physiotherapy centers, sports medicine centers, and orthopedic rehabilitation centers. Also, Europe will benefit from active research work, rising aging population suffering from chronic musculoskeletal conditions, and increasing focus on cutting down dependency on drugs.

Besides, favorable regulatory policies for medical devices, growing number of outpatient rehabilitation centers, and rising demand for portable laser therapy equipment will be encouraging the manufacturers to increase their footprint in Europe. In 2025, the European Society of Physical and Rehabilitation Medicine continued its efforts towards research and education on evidence-based rehabilitation technologies, including photobiomodulation for musculoskeletal rehabilitation and pain management.

Asia Pacific Cold Laser Therapy Market Insights

The Asia Pacific cold laser therapy market is set to witness the fastest growth, as it is growing at a CAGR of 7.92%. Fast growth in healthcare infrastructure, rising healthcare spending, growing availability of rehabilitation centers, and increasing cases of chronic pain disorders have been identified as some of the major factors contributing to the market’s growth in the region. The countries of China, Japan, India, South Korea, and Australia are registering increased investments in physiotherapy clinics, sports medicine clinics, and other advanced rehabilitation technologies.

This is also due to the growth of domestic manufacture of medical devices, better healthcare delivery, and adoption of portable laser therapy systems for home and outpatient treatment. Government efforts toward supporting rehabilitation services, growing innovations in wearable therapeutic devices, and increasing investments in digital healthcare would lead to the acceleration in growth of the market. In 2025, the Japan Physical Therapy Association continued with its efforts toward the promotion of advanced rehabilitation technologies and evidence-based practice in physiotherapy.

Middle East & Africa and Latin America Cold Laser Therapy Market Insights

The Middle East & Africa market is showing signs of progressive expansion owing to continued investments in rehabilitation infrastructure and development of specialized physiotherapy services. Markets such as UAE, Saudi Arabia, and South Africa have been increasingly resorting to modern medical technologies in order to tackle the problem of chronic pain, musculoskeletal conditions, and sport-related injuries. Expansion of the number of private hospitals, rehabilitation centers, and sports medicine clinics is boosting the demand for non-invasive laser therapy systems. Dubai Health in 2025 continued to expand rehabilitation and specialized therapy services within healthcare modernization initiatives.

Latin America is demonstrating continuous growth of the market due to increasing rehabilitation services and sports injuries treatment, improvement of healthcare infrastructure, growing awareness of non-invasive pain management techniques. Brazil, Mexico, Argentina, and Chile are the main drivers of the market due to growing investments in physiotherapy centers and orthopedics. Increasing demand for cost-effective outpatient rehabilitation services, along with increasing access to mobile cold laser therapy systems, is set to create positive business environment for manufacturers. Brazilian Society of Physical Therapy in 2025 continued to support educational initiatives aimed at modern rehabilitation technologies and evidence-based physiotherapy, encouraging the use of photobiomodulation technologies.

Market Dynamics                        

Growth Drivers: Increase in demand for non-invasive pain management and rehabilitation treatments.

Increasing burden of chronic pain, musculoskeletal disorders, sports injuries and orthopedic ailments due to aging worldwide is playing an important role in the use of cold laser therapy. There is increasing use of photobiomodulation by healthcare professionals as a non-invasive and non-pharmacological therapy method that assists in reduction of inflammation, cellular repair, improving blood flow and tissue regeneration without causing any thermal injury. Concerns about opioid addiction, patient acceptance of conservative methods and development of rehabilitation programs have resulted in adoption of laser therapy within hospitals, physiotherapy clinics and sports medicine clinics. Continued promoting evidence-based and non-surgical methods for treatment of musculoskeletal ailments, which encouraged clinicians to focus on advanced rehabilitation technologies like photobiomodulation.

Restraints: Restricted insurance cover and lack of consistency in clinical standardization.   

Although there is an increase in the acceptance of this therapy in a clinical setting, yet this market faces difficulties because of inconsistencies in the payment policies, treatment protocols and standardization of clinical practices. The main problem that arises with many health care institutions is the inconsistent payment for cold laser therapy that varies from one country to another as well as from one payer to another, making this procedure expensive for patients. Moreover, there can be variations in the wavelengths of lasers, time duration, dosage and clinical skills of practitioners that result in inconsistent clinical outcomes. In 2025, the World Physiotherapy initiated efforts to promote standardized evidence-based physiotherapy practice.

Opportunities: Growth in wearable photobiomodulation and at-home rehabilitation devices.

The rapid development of wearable medical devices and digital health technology creates ample opportunities for the growth of the Cold Laser Therapy Market. Growing demand for at-home rehabilitation, remote patient monitoring, and personalized care is motivating companies to develop wearable photobiomodulation technologies that are able to provide continuous treatment beyond the clinical setting. Improved compliance and reduced healthcare cost through integration of wireless connectivity, mobile health apps, AI treatment optimization, and cloud-based patient monitoring are some of the factors driving the market forward. THOR Photomedicine Ltd. continued expanding research and clinical education initiatives related to wearable and portable photobiomodulation in 2025.

Recent Developments

• 2026: Erchonia continued expanding clinical evidence and educational initiatives supporting FDA-cleared low-level laser therapy applications for pain management and rehabilitation.

• 2025: THOR Photomedicine advanced international photobiomodulation education and research collaborations focused on musculoskeletal rehabilitation, neurological recovery, and wound healing.

• 2025: Multi Radiance Medical strengthened its laser therapy portfolio through expanded clinical training and adoption initiatives supporting rehabilitation and sports medicine professionals.

• 2026: Zimmer MedizinSysteme continued enhancing its physiotherapy and laser therapy product portfolio with advanced rehabilitation technologies for clinical practice.

Cold Laser Therapy Market Key Players are:               

• Erchonia Corporation

• THOR Photomedicine Ltd.

• Multi Radiance Medical

• Zimmer MedizinSysteme GmbH

• BTL Industries

• Enovis Corporation

• LiteCure LLC

• ASA Laser

• EMS Physio Ltd.

• Omega Laser Systems Ltd.

• RJ-Laser GmbH

• K-Laser USA

• IRRADIA AB

• PowerMedic ApS

• Weber Medical GmbH

• BioFlex Laser Therapy

• Good Energies Ltd.

• Wuhan Gigaa Optronics Technology Co., Ltd.

• Apira Science Inc.

• Summus Medical Laser

Cold Laser Therapy Market Report Scope: